Nuvo Research Inc. (NRI.TO) Announces 2012 Third Quarter Results  
11/1/2012 9:51:52 AM

MISSISSAUGA, ON, Oct. 31, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the third quarter ended September 30, 2012.